Skip to main content

 

FEED
From 30,000+ hand-picked sources

Clarient Gains Rights to the ALK Cancer Biomarker from Insight Genetics

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Read More

GSK, Canadian Center Launch Funds to Bolster Commercialization of Research

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Read More

Majority in GEN Poll Sees at Least Some Use for Bioeconomy Blueprint

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Read More

IntelligentMDX Wins CE Mark for Group B Strep Assay on Abbott m2000 Instrument

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Read More

GEN

Read More

Advertisement
G.E.N.

Exclusives

G.E.N.

On Sale